Christopher R. Aiken, Ph.D.

Professor of Pathology, Microbiology and Immunology
Cornelius Vanderbilt Chair in Pathology, Microbiology and Immunology
Vanderbilt University School of Medicine
A-5301 Medical Center North
1161 21st Ave. S.
Nashville
Tennessee
37232-2363
(615) 343-7037

Biochemistry and molecular biology of HIV infection; Antiviral mechanisms

Dr. Aiken, is the program director of the Microbe-Host Interactions Ph.D. Program, a Professor of Pathology, Microbiology and Immunology and the Cornelius Vanderbilt Chair in Pathology, Microbiology and Immunology at Vanderbilt University Medical Center. 

Research Information

The focus of the Aiken lab is to understand the molecular events governing HIV replication in order to develop novel antiviral therapies. We use the tools of biochemistry, molecular biology, and cell biology to study virus-host cell interactions. We also collaborate with structural biologists to understand the structure and function of the viral capsid. We are particularly interested in interactions between virus and host cell proteins. Current projects include:

  1. HIV-1 capsid structure and function (Cell 139:780-90, 2009; Nature 497:643-6, 2013).
  2. Role of host cell proteins in HIV-1 infection (J. Virol. 82:12001-8, 2008; J. Virol. 87:422-32, 2013).
  3. Mechanism of HIV-1 restriction by TRIM5alpha (PLos Pathog. 4(5):e1000074, 2008; J. Virol. 84:6564-69, 2010; PLos Path 7:e1002009, 2011; J. Virol. 87:9271-8, 2013).
  4. Identification and mechanisms of HIV-1 capsid inhibitors (J. Virol. 85:542-9, 2011).
  5. Conformational Masking of HIV-1 Env proteins during virion maturation (PLoS Pathog 7:e1002234, 2011).

Publications on PubMed.gov